Eloxx Pharmaceuticals, Inc. (ELOX): Depreciation & Amortization
Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2017-06-30, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$44.1K
Year ended 2017-06-30
-49.9%
3-year compound annual growth
-29.8%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2017-06-30 | $44.1K | -52.8% | 2017-10-13, From 2016-07-01 |
| 2016-06-30 | $93.4K | -47.3% | 2017-10-13, From 2015-07-01 |
| 2015-06-30 | $177.1K | -49.4% | 2017-10-13, From 2014-07-01 |
| 2014-06-30 | $349.7K | +19.1% | 2016-10-13, From 2013-07-01 |
| 2013-06-30 | $293.6K | +13.8% | 2015-10-09, From 2012-07-01 |
| 2012-06-30 | $258.0K | +80.1% | 2014-09-29, From 2011-07-01 |
| 2011-06-30 | $143.3K | +13.2% | 2013-09-11, From 2010-07-01 |
| 2010-06-30 | $126.6K | n/a | 2012-10-26, From 2009-07-01 |